Table 3 Efficacy and hepatic complications of three endovascular treatment approaches
Total (N = 18) | Hepatic artery sacrifice group(N = 11) | Superselective embolization group (N = 4) | Covered stent group (N = 3) | |
|---|---|---|---|---|
Technical success - number(%) | 18 (100) | 11 (100) | 4 (100) | 3 (100) |
Recurrent hemorrhage - number(%) | 7 (39) | 2 (18) | 4 (100) | 1 (33) |
Hospital stay - mean (SD) | 75 (53) | 61 (49) | 103 (66) | 91 (53) |
30-day mortality - number(%) | 2 (11) | 2 (18) | 0 (0) | 0 (0) |
1-year mortality- number(%) | 4 (24), N = 17 | 2 (20), N = 10 | 1 (25) | 1 (33) |
Major hepatic complications | 10 (56) | 6 (55) | 2 (50) | 2 (67) |
Hepatic failure - number(%) | 5 (28) | 3 (27) | 1 (25) | 1 (33) |
Hepaitc abscess - number(%) | 6 (33) | 4 (36) | 1 (25) | 1 (33) |
Minor hepatic complication - number(%) | 15 (83) | 8 (73) | 4 (100) | 3 (100) |